FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895541191> ?p ?o ?g. }

• W2895541191 endingPage "e0204982" @default.
• W2895541191 startingPage "e0204982" @default.
• W2895541191 abstract "Background Tuberculosis (TB) patients with human immunodeficiency virus (HIV) co-infection have worse TB treatment outcomes compared to patients with TB alone. The distribution of unfavourable treatment outcomes differs by socio-demographic and clinical characteristics, allowing for early identification of patients at risk. Objective To develop a statistical model that can provide individual probabilities of unfavourable outcomes based on demographic and clinical characteristics of TB-HIV co-infected patients. Methodology We used data from all TB patients with known HIV-positive test results (aged ≥15 years) registered for first-line anti-TB treatment (ATT) in 2015 under the Revised National TB Control Programme (RNTCP) in Delhi, India. We included variables on demographics and pre-treatment clinical characteristics routinely recorded and reported to RNTCP and the National AIDS Control Organization. Binomial logistic regression was used to develop a statistical model to estimate probabilities of unfavourable TB treatment outcomes (i.e., death, loss to follow-up, treatment failure, transfer out of program, and a switch to drug-resistant regimen). Results Of 55,260 TB patients registered for ATT in 2015 in Delhi, 928 (2%) had known HIV-positive test results. Of these, 816 (88%) had drug-sensitive TB and were ≥15 years. Among 816 TB-HIV patients included, 157 (19%) had unfavourable TB treatment outcomes. We developed a model for predicting unfavourable outcomes using age, sex, disease classification (pulmonary versus extra-pulmonary), TB treatment category (new or previously treated case), sputum smear grade, known HIV status at TB diagnosis, antiretroviral treatment at TB diagnosis, and CD4 cell count at ATT initiation. The chi-square p-value for model calibration assessed using the Hosmer-Lemeshow test was 0.15. The model discrimination, measured as the area under the receiver operator characteristic (ROC) curve, was 0.78. Conclusion The model had good internal validity, but should be validated with an independent cohort of TB-HIV co-infected patients to assess its performance before clinical or programmatic use." @default.
• W2895541191 created "2018-10-12" @default.
• W2895541191 creator A5001478992 @default.
• W2895541191 creator A5005524174 @default.
• W2895541191 creator A5018736190 @default.
• W2895541191 creator A5025019787 @default.
• W2895541191 creator A5027759136 @default.
• W2895541191 creator A5028204521 @default.
• W2895541191 creator A5030917190 @default.
• W2895541191 creator A5040245212 @default.
• W2895541191 creator A5058735208 @default.
• W2895541191 creator A5075720122 @default.
• W2895541191 creator A5075858666 @default.
• W2895541191 creator A5082555316 @default.
• W2895541191 creator A5091279201 @default.
• W2895541191 date "2018-10-03" @default.
• W2895541191 modified "2023-09-29" @default.
• W2895541191 title "Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India" @default.
• W2895541191 cites W1043277833 @default.
• W2895541191 cites W1991628482 @default.
• W2895541191 cites W1994224528 @default.
• W2895541191 cites W2024889613 @default.
• W2895541191 cites W2044220240 @default.
• W2895541191 cites W2046917299 @default.
• W2895541191 cites W2082376914 @default.
• W2895541191 cites W2121815876 @default.
• W2895541191 cites W2131587651 @default.
• W2895541191 cites W2171642892 @default.
• W2895541191 cites W2281690237 @default.
• W2895541191 cites W2514833394 @default.
• W2895541191 cites W2533279624 @default.
• W2895541191 cites W3147809485 @default.
• W2895541191 cites W791943867 @default.
• W2895541191 doi "https://doi.org/10.1371/journal.pone.0204982" @default.
• W2895541191 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6169917" @default.
• W2895541191 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30281679" @default.
• W2895541191 hasPublicationYear "2018" @default.
• W2895541191 type Work @default.
• W2895541191 sameAs 2895541191 @default.
• W2895541191 citedByCount "8" @default.
• W2895541191 countsByYear W28955411912020 @default.
• W2895541191 countsByYear W28955411912021 @default.
• W2895541191 countsByYear W28955411912022 @default.
• W2895541191 countsByYear W28955411912023 @default.
• W2895541191 crossrefType "journal-article" @default.
• W2895541191 hasAuthorship W2895541191A5001478992 @default.
• W2895541191 hasAuthorship W2895541191A5005524174 @default.
• W2895541191 hasAuthorship W2895541191A5018736190 @default.
• W2895541191 hasAuthorship W2895541191A5025019787 @default.
• W2895541191 hasAuthorship W2895541191A5027759136 @default.
• W2895541191 hasAuthorship W2895541191A5028204521 @default.
• W2895541191 hasAuthorship W2895541191A5030917190 @default.
• W2895541191 hasAuthorship W2895541191A5040245212 @default.
• W2895541191 hasAuthorship W2895541191A5058735208 @default.
• W2895541191 hasAuthorship W2895541191A5075720122 @default.
• W2895541191 hasAuthorship W2895541191A5075858666 @default.
• W2895541191 hasAuthorship W2895541191A5082555316 @default.
• W2895541191 hasAuthorship W2895541191A5091279201 @default.
• W2895541191 hasBestOaLocation W28955411911 @default.
• W2895541191 hasConcept C126322002 @default.
• W2895541191 hasConcept C142724271 @default.
• W2895541191 hasConcept C151956035 @default.
• W2895541191 hasConcept C187212893 @default.
• W2895541191 hasConcept C203014093 @default.
• W2895541191 hasConcept C2776301714 @default.
• W2895541191 hasConcept C2777025531 @default.
• W2895541191 hasConcept C2777813720 @default.
• W2895541191 hasConcept C2777975735 @default.
• W2895541191 hasConcept C2781069245 @default.
• W2895541191 hasConcept C2781413609 @default.
• W2895541191 hasConcept C3013748606 @default.
• W2895541191 hasConcept C71924100 @default.
• W2895541191 hasConceptScore W2895541191C126322002 @default.
• W2895541191 hasConceptScore W2895541191C142724271 @default.
• W2895541191 hasConceptScore W2895541191C151956035 @default.
• W2895541191 hasConceptScore W2895541191C187212893 @default.
• W2895541191 hasConceptScore W2895541191C203014093 @default.
• W2895541191 hasConceptScore W2895541191C2776301714 @default.
• W2895541191 hasConceptScore W2895541191C2777025531 @default.
• W2895541191 hasConceptScore W2895541191C2777813720 @default.
• W2895541191 hasConceptScore W2895541191C2777975735 @default.
• W2895541191 hasConceptScore W2895541191C2781069245 @default.
• W2895541191 hasConceptScore W2895541191C2781413609 @default.
• W2895541191 hasConceptScore W2895541191C3013748606 @default.
• W2895541191 hasConceptScore W2895541191C71924100 @default.
• W2895541191 hasIssue "10" @default.
• W2895541191 hasLocation W28955411911 @default.
• W2895541191 hasLocation W28955411912 @default.
• W2895541191 hasLocation W28955411913 @default.
• W2895541191 hasLocation W28955411914 @default.
• W2895541191 hasLocation W28955411915 @default.
• W2895541191 hasOpenAccess W2895541191 @default.
• W2895541191 hasPrimaryLocation W28955411911 @default.
• W2895541191 hasRelatedWork W1661793699 @default.
• W2895541191 hasRelatedWork W2041072016 @default.
• W2895541191 hasRelatedWork W2083118149 @default.
• W2895541191 hasRelatedWork W2363604371 @default.
• W2895541191 hasRelatedWork W2623852134 @default.

• next